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Abstract
Background: Uncharacterized proteases naturally expressed by bacterial pathogens represents important topic in
infectious disease research, because these enzymes may have critical roles in pathogenicity and cell physiology. It
has been observed that cloning, expression and purification of proteases often fail due to their catalytic functions
which, in turn, cause toxicity in the E. coli heterologous host.
Results: In order to address this problem systematically, a modified pipeline of our high-throughput protein
expression and purification platform was developed. This included the use of a specific E. coli strain, BL21(DE3)
pLysS to tightly control the expression of recombinant proteins and various expression vectors encoding fusion
proteins to enhance recombinant protein solubility. Proteases fused to large fusion protein domains,
maltosebinding protein (MBP), SP-MBP which contains signal peptide at the N-terminus of MBP, disulfide
oxidoreductase (DsbA) and Glutathione S-transferase (GST) improved expression and solubility of proteases. Overall,
86.1% of selected protease genes including hypothetical proteins were expressed and purified using a combination
of five different expression vectors. To detect novel proteolytic activities, zymography and fluorescence-based
assays were performed and the protease activities of more than 46% of purified proteases and 40% of hypothetical
proteins that were predicted to be proteases were confirmed.
Conclusions: Multiple expression vectors, employing distinct fusion tags in a high throughput pipeline increased
overall success rates in expression, solubility and purification of proteases. The combinatorial functional analysis of
the purified proteases using fluorescence assays and zymography confirmed their function.
Background
Proteases represent one of the largest protein families,
and play critical roles in cellular functions and viability
in all organisms [1,2]. Proteases have diverse biological
roles in signal transduction, post-translational modifica-
tion, proliferation, apoptosis and pathogenicity through
specific processing or non-specific degradation [3-6].
Proteases can be classified into two categories, secreted
proteases and intracellular proteases [7]. Secreted pro-
teases such as trypsin, usually cleave at specific short
recognition sites of proteins or peptides. In contrast,
substrates of intracellular proteases are much more
specific, preventing uncontrolled degradation of cellular
compartments. Major functions of intracellular proteases
include clearing damaged proteins and playing roles as a
part of regulatory pathways through the degradation of
specific substrates [7-9]. For example, ClpXP in Y. pestis
and Lon proteases contribute to the environmental reg-
ulation of the Y. pestis T3SS system through regulated
proteolysis of YmoA [10]. Another example is a prenyl-
protein-specific endoprotease that is involved in the
post-translational modification processing steps of
CAAX motif proteins [11]. Proteases also play key roles
in the immune system for both defense mechanisms of
host cells and pathogenicityi nav a r i e t yo fp a t h o g e n s
from viruses to higher parasites [11-16]. For example,
IgA protease, an essential protein of S. pneumoniae
in lung infection, targets a host immune response,
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any medium, provided the original work is properly cited.secretory IgA [17]. Proteases of pathogens are potential
therapeutic targets and therefore an understanding of
their mechanisms and the discovery of new proteases
are also important for defining novel drug targets
[18-20].
Proteases can be also categorized as exopeptidases and
endopeptidases [21]. Exopeptidases cleave peptide bonds
at either the amino or carboxyl termini and sequentially
hydrolyze amino acids. Endopeptidases cleave peptide
bonds within the proteins. Endopeptidases may be
further sub-divided into four types according to their
catalytic mechanism: serine, cysteine, aspartic and
metallo proteases. Serine proteases recognize specific
cleavage site through their specificity pockets and cata-
lyze the peptide bond cleavage using a conserved cataly-
tic triad consisting of histidine, serine and aspartate
[22]. Cysteine proteases use a similar catalytic triad as
serine proteases except that a cysteine residue is recog-
nized instead of serine. Aspartic proteases use two acidic
residues in the catalytic process and metalloproteases
use a metal ion and a glutamic acid to catalyze proteoly-
sis both using a water molecule to cleave the peptide
bond directly. Metalloproteases are comprised of 51
families and half of them fall into 3 clans, MA, MB and
MX/MBA. They have common zinc binding motif,
HEXXH and an additional zinc coordinating residue
[23-25].
Due to the catalytic activity and biological conse-
quences of peptide bond cleavage, proteases represent
one of the most challenging functional groups of pro-
teins for heterologous expression and purification. Pro-
duction of unregulated foreign proteases in E. coli host
cells represents a critical stress often resulting in the
formation of inclusion bodies, non-expression, or cyto-
toxicity [26-28]. Therefore, the large-scale study of pro-
teases is challenging. According to a previous statistical
analysis in genome-wide expression and purification of
S. pneumoniae proteins using an expression vector pHis,
success frequencies of proteases were 37% for cloning,
and only15% for recovery of soluble expressed recombi-
nant protein [29].
T h ef u s i o nt a g su s e di nt h eexpression and purifica-
tion of recombinant proteins are crucial components.
Numerous tags have been utilized in detection, quantifi-
cation, enhancement of expression and solubility, immo-
bilization and purification of proteins [30-35]. The His-
tag, maltose-binding protein (MBP), glutathione S-trans-
ferase (GST), thioredoxin (Trx) and the transcription
termination anti-termination factor (NusA) are the most
frequently used fusions tag. The His-tag and GST are
widely used for affinity purification. These tags can also
be used for detection of recombinant proteins and
immobilization [30,36]. S-tag and green fluorescence
protein (GFP) are used for detection and quantification
of proteins [37,38]. Beside those fusion tags, Halo-tag is
a more recently developed fusion tag for affinity purifi-
cation, detection, immobilization and enhancing solubi-
lity of proteins [39]. The large fusion tags such as Trx,
GST, MBP, NusA and Halo-tag generally enhance solu-
bility of recombinant proteins. The comparison of
expression and solubility of proteins by various fusion
tags has been studied previously [40-46]. Although
many of these studies represented limited scale exami-
nations, they showed different expression and solubility
level by fusion tags and target proteins. Therefore, a
protein expression and purification platform would
return maximum success by employing a combination
of fusion tags.
In this study, we address the following objectives; 1)
large-scale protein expression and purification of pro-
teases derived from bacterial pathogens, 2) evaluating
the efficiency of different fusion tags using multiple
expression vectors in combination, and 3) high through-
put assay development for protease screening and con-
firmation of activities of predicted proteases. A set of
187 protease candidates were selected using bioinfor-
matics tools. These protease candidates were mined
from three pathogenic bacteria, Streptococcus pneumo-
niae TIGR4, Bacillus anthracis Ames and Yersinia pestis
KIM. The protease set was used for studies in cloning,
expression, purification and function using various
fusion tags including hexa-histidine (His-tag), maltose
binding protein (MBP), MBP with signal peptide
(SP-MBP), disulfide oxydoreductase A (DsbA) and glu-
tathione S-transferase (GST). The combination of the
fusion tags provides high success rates (86.6%) in the
recovery of soluble expressed target proteins. Nearly all
of these (86.1%) were purified successfully. Protease
activities of the purified proteins were also examined
using a high throughput fluorescence-based assay and
zymography, that not only support the annotation as a
protease or putative protease but also identified the pro-
tease activity of hypothetical proteins and a protein
annotated as a non-protease.
Results
Overview of the pipeline
The high throughput protein production pipeline is
based on a 96-well format procedure. The pipeline con-
sists of cloning, DNA sequence validation, expression,
purification, confirmation of protein identity by mass
spectroscopy and storage. One of the essential features
of our pipeline is the cloning of ORFs into multiple
expression vectors. Gateway cloning technology was
introduced in the pipeline in order to maintain efficient
cloning in this regard (Figure 1). When a single expres-
sion vector encoding the His-tag is used to overexpress
randomly selected recombinant proteins in E. coli,
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40% of target genes [29,47]. If the selected genes are
toxic to the host cells, the final yields are decreased
further. However, when multiple expression vectors are
used to prepare protein, the overall success rates of
expression, solubility and purification of target proteins
can be significantly increased. The Gateway cloning sys-
tem represents an ideal cloning method to produce
multiple expression vectors for use in a high throughput
protein production pipeline. Once entry clones are pre-
pared and their sequences are validated, the entry clones
may be used to generate expression clones using desti-
nation vectors encoding a variety of fusion tags by sim-
ply shuttling ORFs into multiple Gateway compatible
expression vectors using the recombinase, LR clonase.
Multiple expression vectors shown in Figure 1 were
Figure 1 Gateway compatible expression vectors with different fusion tags.
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Gateway cloning system in order to improve expression
and solubility of recombinant proteins. Unlike methods
using restriction enzymes, Gateway cloning is very effi-
cient and sequence validated entry clones can be used
for any Gateway destination vector without further
DNA sequence validation. Although the pET system is
very powerful, it lacks tight control of expression. The
expression control of proteins is critical for successful
expression of potentially toxic proteins. Proteases repre-
sent a strong example for which expression control is
important due to cytotoxic proteolytic activities. The
early undesired expression of target proteins using pET
expression system was suppressed by addition of glucose
in the media and using BL21(DE3)pLysS. A primary car-
bon source for E. coli host, glucose binds to the lac
repressor and shut off transcription of the T7 RNA
polymerase gene under the control of the lac UV5 pro-
moter. Low level expression of T7 lysozyme from pLysS
binds to and inhibits T7 RNA polymerase. Approxi-
mately, 86.1% of cloned ORFs were expressed and puri-
fied with at least one of expression vectors. By batch
purification using 2 mL 96-well filter block, between 2 -
200 μg of recombinant proteins were obtained. Purity of
the recombinant proteins was dependent upon the
amount of soluble expressed recombinant protein and
ranged between 80-95%. The purity of the recombinant
proteins were confirmed by Nu-PAGE gel analysis
(Figure 2) and the identity of the purified proteins were
confirmed by in-gel trypsin digestion followed by
MALDI-TOF/TOF analysis.
Expression vector comparison
The levels of expressions and solubility of recombinant
proteins are directly related to the expression vector
used and a variety of known and unknown protein char-
acteristics. Consequently, the solubility levels of
expressed proteins directly contribute to the final yield
of purified proteins as shown in Figure 2. Expression
and solubility of the recombinant proteins were esti-
mated by Coomassie blue and/or InVision His-tag stain-
ing of Nu-PAGE gels. A simple expression vector, pHis
which contains an NH2-terminal His-tag, does not
enhance solubility of overexpressed proteins [29]. In
order to increase solubility of recombinant proteins,
additional fusion tags such as MBP, GST or DsbA were
u s e df u s e da tt h eN - t e r m i n u s .T w oM B Pf u s i o nt a g
expression vectors were constructed. One, named
pMBP, lacks the signal peptide (SP), but contains a His-
tag just upstream of the MBP segment. The other,
named pSP-MBP, was engineered with a SP at the
N-terminal end of MBP. Like pSP-MBP, an expression
vector, pDsbA also contains a signal peptide as a part of
the fusion. In the expression vectors containing a signal
peptide, the His-tag is located at the C-terminal end of
MBP and DsbA. The expression vector pGST (pEXP7)
containing an N-terminal GST fusion tag, lacks a His-tag
while all other vectors contain a His-tag for immobilized
metal affinity chromatography (IMAC) purification and
the GST fused recombinant proteins were purified using
Glutathione agarose resin. TEV protease treatment
removes tags from recombinant protein for the vectors,
pMBP, pSP-MBP and pDsbA.
The expression and solubility of recombinant proteins
were examined by Nu-PAGE with His-tag staining (In-
Vision) and/or Coomassie blue staining. The expression
and solubility of recombinant proteins were scored as
“0”, “1”, “2”,a n d“3” that represent undetectable, low,
medium and high expression and solubility, respectively
(Additional file 1, Table S1). Unexpectedly, not only
solubility but also expression success frequency was
dependent on the types of fusion tags used as described
in Figure 3. The smallest fusion tags in the series, His-
tag of pHis expression vector showed the least success
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Figure 2 C o o m a s s i eb l u es t a i n e dN u - P A G Eg e lo fp u r i f i e d
proteases. The proteins were expressed using pMBP vector and
purified using Ni-NTA agarose resin as described in Materials and
Methods. The purity of proteases was confirmed on the Nu-PAGE
gel and the concentrations were determined by Bradford assay with
BSA standard curve. (M: marker, 1: SP_1467, conserved hypothetical
protein, 2: SP1477, hypothetical protein, 3: y0125, sigma cross-
reacting protein 27A, 4: y0137, protease DO, 5: y0720, putative PhnP
protein, 6: y0746, cytosol aminopeptidase, 7: y1280, pyrrolidone-
carboxylate peptidase, 8: y2013, putative pepetidase, 9: y2057,
peptidase U7 family SohB protein, 10: y2527, prolyl oligopeptidase
family protein, 11: y2694, conserved hypothetical protein, 12:
y3230,4-methyl-5(b-hydroxyethyl)-thiazole monophosphate
biosynthesis protein, 13: y3297, proline-specific aminopeptidase, 14:
y3855, oligopeptidase A, 15: y3857, putative alkaline
metalloproteinase).
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cloned into the pSP-MBP or pDsbA containing the
E. coli signal peptide at the N-terminal end of fusion
tags displayed marginally lower success frequencies
compared to the other expression vectors examined.
The MBP fusion tag in our studies is superior to other
tags at all stages from expression to purification. With
pMBP alone, 133 proteases (71%) were purified com-
pared to a total 161 different proteases (86.1%) success-
fully purified by employing a series of expression
vectors. The most effective combination of three expres-
sion vectors are pSP-MBP, pMBP and pDsbA which
resulted in the successful purification of 159 (85%) pro-
teases, nearly the same success as that achieved using all
Figure 3 Comparison of success frequencies of expression vectors at each stage of purification. Selected entry clones of 187 ORFs in
Bacillus anthracis Ames, Streptococcus pneumonia TIGR4 and Yersinia pestis KIM, were used to prepare expression clones using 5 different Gateway
comparable vectors, pHis, pMBP, pSP-MBP, pDsbA and pGST. Target proteins were expressed in 96-well blocks by IPTG induction at OD600 nm =
0.7-0.9 for 20 hours at 20°C. The harvested cell pellets were resuspended in lysis buffer [50 mM Tris-HCl, 100 mM NaCl, 1 mM DTT at pH 7.8 at
4°C] and lysed using PopCulture and lysonase. The recombinant proteins were purified using Ni-NTA agarose column as described in ‘Methods
and Materials’.
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expression vectors were pMBP and pSP-MBP or pMBP
and pDsbA generating success rates of 79.7% and 78.6%,
respectively. Expression vectors encoding NH2-terminal
signal peptide, such as pSP-MBP and pDsbA resulted in
a relatively larger number of purified proteins compared
to pHis, however to protein recovered from 1 mL cul-
ture, resulted in poor yields of purified proteins. In
order to increase the final yield of purified proteins, 4
x1 mL cultures were used. The average concentrations
of purified proteins from pHis, pMBP, pSP-MBP, pDsbA
and pEXP7 were 440, 138, 334, 53 and 21 μg/mL,
respectively. The purification success rate of S. pneumo-
niae, B. anthracis and Y. pestis proteases were 88.2%,
78.0% and 93.4%, respectively. Proteases of B. anthracis
were marginally more difficult to express and purify.
Protein localization is a critical factor for protein
purification success
Characteristics of proteins, such as sub-cellular localiza-
tion, and localization the presence of signal peptides, are
among the most critical factors for expression, solubility
and purification. The purified recombinant proteins
were confirmed by SDS-PAGE. Because protein purifica-
tion success rates represent soluble expression of pro-
teins, the correlation between purification and the
protein sub-cellular localization were examined. The
dependence of purification success rate on the protein
localization was clearly evident (Figure 4). Cytoplasmic
proteins displayed the highest purification success rate.
Proteins with predicted membrane localization and sur-
face were successful in less than 40% of the cases. More
than 97% of the attempted cytoplasmic proteins were
expressed and purified by at least one of the expression
vectors, while 68.1% of non-cytoplasmic proteins were
successfully purified. The expression vector, pHis is the
least favorable for surface proteins. The other larger
fusion proteins increased purification of the surface pro-
teins. The MBP-tag increased the success rate of the
surface proteases by approximately 8-fold compared to
the His-tag. The presence of signal peptide that targets
proteins to the cell surface also decreased the success
rate of protein purification. Only one of 38 attempted
proteins containing native signal peptide were purified
using the pHis expression vector. The expression vector
with the GST-tag also performed poorly for proteins
containing signal peptide. Half of the proteins contain-
ing signal peptide were purified using an expression vec-
tor, pMBP, which was also the most successful vector
for both the presence and the absence of signal peptide.
Approximately 20-fold more proteases containing signal
peptide were purified with pMBP compared to pHis.
With a combination of 5 expression vectors, 79% of pro-
teins containing native signal peptide were purified.
Protease activity characterization
The activities of purified proteases were examined using
gelatin zymography and/or a fluorescence-based assay.
Although zymography has limitations associated with
the case of variability of proteins refolding to a native
form after separation on SDS-PAGE, it is still a robust
method for confirming protease activities. An example
of a zymogram is shown in Figure 5. A putative micro-
bial collagenase of B. anthracis was applied to zymo-
graphic analysis. The expression of the collagenase was
very low and roughly 50% of the protein was solubilized.
The total amount of the purified putative collagenase
from 1 mL culture was only approximately 1.6 μg. The
enzyme activity was confirmed by applying 2 ng of the
collagenase on gelatin zymography. The result was
shown in the lane C in Figure 5. The activity of the col-
lagenase was compared with the activity of 2.5 ng of
Trypsin shown in lane T. Three putative microbial col-
lagenases in B. anthracis were annotated and all of them
were purified with a series of fusion tags. All of the pur-
ified collagenases showed activities for gelatin but not
for BZAR (Table 1 Additional file 1Table S1). In addi-
tion to the putative collagenases, activities of four more
proteases were confirmed by zymography.
Alternative fluorescence assay for serine proteases
were performed using a well-known Rhodamine 110-
based serine protease substrate, bis-(CBZ-L-arginine
amide), dihydrochloride (BZAR). The structure of BZAR
and scheme are shown in Figure 6. Upon enzymatic
cleavage, the non-fluorescent bisamide substrate in con-
verted to monoamide and then to rhodamin110 which
can be easily monitored by fluorescence increase. The
fluorescence changes of BZAR upon adding proteases
were monitor for one hour. Positive slopes represent the
hydrolysis of peptide in BZAR. Two criteria were used
to confirm the protease activity, the slope and the ratio
of signal to noise (S/N). Thresholds of the slope and
ratio of S/N were defined as 0.015 and 2, respectively. A
total of 74 proteases were confirmed to have activity by
fluorescence assays using BZAR and DQ and gelatin
zymography (Table 2). Among the list of confirmed pro-
teases were 44 hypothetical proteins which were pre-
dicted to be proteases based on analysis using Prosite
motif search, protein family analysis (PFAM) and/or,
Clusters of Orthologous Groups of proteins (COGs),
and 43.2% of the candidates tested displayed protease
activity. A protein annotated as a putative kinase in
Y.pestis also displayed protease activity.
Confirmed activities of purified proteases were depen-
dent on the fusion tags used. A relatively large number
of proteases were purified using the pMBP expression
vector, but only approximately 11% of them were con-
firmed for protease activity. A similar numbers of
proteins were confirmed that were purified from other
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teins using pSP-MBP displayed protease activity. The
pSP-MBP vector contains maltose binding protein
(MBP) as an N-terminal fusion tag like pMBP, and the
E. coli signal peptide at the N-terminus of the MBP and
hexa-histidine tag between the MBP and Gateway clon-
ing site. Based on mass spectroscopy analysis, the signal
peptides were processed during expression of the target
proteins (Data not shown). Although purification yields
of proteases using the expression vector, pSP-MBP were
Figure 4 Dependence of purification success rates on fusion tags and sub-cellular localization of proteins. Analysis of purification
success rate by expression vectors and (A) subcellular localization of proteins or (B) presence of signal peptide.
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higher than protease with other fusion tags.
Discussion
In this study, two elements of the previous platform of
protein expression and purification have been modified
- E. coli expression strain and multiple fusion tags
[29,40-46]. All of the vectors contain T7 promoters for
overexpression in the same E. coli expression strain,
BL21(DE3)pLysS in order to maintain tight control of
protein expression while BLR(DE3) was used for large-
scale expression and purification of proteins in Strepto-
coccus pneumoniae TIGR4 in a previous study [29,48].
The modified platform used IPTG induction while the
previous platform was based on a combination of auto-
induction and IPTG induction. We were able to suc-
cessfully express only 15% of the proteases as soluble
protein with T02 (pHis) vector in the previous study.
One of the major hurdles was the preparation of expres-
sion clones and transformation into BLR(DE3) as well as
the expression soluble proteins. For the same targets in
this study, previously 26% of them were expressed in
soluble form in BLR(DE3) while 38% of them were
expressed in soluble form in BL21(DE3)pLysS.
In order to efficiently clone target genes into five
expression vectors, a Gateway based cloning strategy
was employed in a high throughput protein expression
and purification pipeline [29,47,48]. The prepared entry
clones of target genes were sequence validated and used
to shuttle the cloned ORFs into Gateway compatible
expression vectors. The cloning efficiency of each
expression vector was high except in the case of pEXP7.
The extra amino acids residues present in recombinant
proteins due to Gateway cloning site attB1 and attB2
were identical in all of the expressed proteins.
Therefore, the expression, solubility and purification
yields were mostly dependent on the specific fusion
tag used. The His-tag is one of the most popular
fusion partners for IMAC, but it showed lower success
in expression compared to other fusion tags. In con-
trast, the 44.3 KDa signal peptide deleted maltose
binding protein (MBP) improved the expression and
solubility of target proteins substantially [40,41,49].
The frequency and level of expression achieved with
MBP is superior to other fusion tags examined in this
study. Almost all expressed proteins with the MBP tag
were soluble. However, expressed proteins containing a
signal peptide at the N-terminus of MBP (SP-MBP)
showed different patterns of expression and solubility
compared to the proteins with MBP fusion alone. Two
expression vectors, pSP-MBP and pDsbA contain sig-
nal peptides at the N-terminal end of the fusion tags
and the frequencies of expression and soluble proteins
expressed using two vectors were similar. DsbA, an
E. coli periplasmic enzyme also has signal peptide to
allow protein translocation across the membrane and
the catalysis of disulfide bond formation [32]. When
recombinant proteins targeted to the periplasm are
overexpressed, the translocation machinery of the
E. coli host cell may become overloaded leading to a
decrease in the translocation efficiency. The recombi-
nant proteins may become trapped in the inner
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Figure 5 Detection of protease activity using gelatin
zymogram. A putative collagenase in Bacillus anthracis Ames was
cloned in pMBP and expressed in BL21(DE3)pLysS. Expression (E)
and solubility (S) of the putative collagenase (BA0555) were
confirmed by His-vision staining on Nu-PAGE. The purified protein
was run on Nu-PAGE gel and stained with Coomassie blue to
confirm the purity (P). Gelatin zymogram was performed to examine
protease activity using 2 ng of the purified putative collagenase (C).
Purification background using E. coli supernatant (B) and 2.5 ng of
trypsin (T) were used as a negative and a positive control,
respectively.
Table 1 Activity screen of purified putative microbial collagenases in Bacillus anthracis Ames using different
expression vectors
Gene pHis (T02) pMBP (T221) pSP-MBP (T213) pDsbA (T03) pGST (pEXP7)
DQ Gelatin DQ Gelatin DQ Gelatin DQ Gelatin DQ Gelatin
BA0555 N/A N/A + + + + + + N/A N/A
BA3299 N/A N/A + + + + N/A N/A - +
BA3584 + + + + + + + + - +
N/A: not available, +: activity detected and -: no activity detected.
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proteolyzed in the cytoplasm [50-52].
According to the mass spectroscopy analysis of puri-
fied recombinant proteins, the signal peptides of the
fusion tags SP-MBP and DsbA are effectively removed
from the N-terminal end of expressed proteins. The sig-
nal peptide of the protein of interest itself was not pro-
cessed due to the location of SP between MBP tag and
protein of interest. The low yield purification of SP-
M B Pt a g g e dp r o t e i n sw e r eo v e r c o m eb ys c a l i n gu pt h e
volume of bacterial cultures by four-fold. However, the
presence of the signal peptide associated with the pro-
tein of interest did not correlate to functional activity of
the protease expressed with SP-MBP.
Based on the protease assays performed, 19 proteins
annotated as hypothetical proteins were confirmed to
have protease activity. One of the proteins, annotated as
a putative kinase, showed protease activity based on the
BZAR assay. The protein is annotated as a putative
kinase (YPO0966) in Yersinia pestis CO92 and the
orthologous protein in Yersinia pestis KIM is annotated
as a hypothetical protein (y3353). According to NCBI
Blast, it belong to Pfam01551 (protein family) which
encodes peptidase M23. This protein is also a member
of COG0739 (Clusters of Orthologous Groups of pro-
teins) of membrane proteins related to metallo-endo-
peptidases. The three putative collagenases in Bacillus
anthracis, BA0555, BA3299 and BA3584 were also
confirmed in their putative activity by gelatin zymogra-
phy and a robust DQ gelatin fluorescence assay. The
activities of the putative collagenases clearly were
observed by both methods except in the case of GST-
tagged putative collagenases. The activities of the puri-
fied GST-tagged putative collagenases would be recov-
ered during denaturation and renaturation process
during zymography. According to alignment using
LALIGN http://www.ch.embnet.org/software/LALIGN_-
form.html, pair-wise identity scores of the three putative
collagenases are between 58.2% - 71.6% [53]. All of
them contain a peptidase M9 domain which is found in
microbial collagenase metalloproteases. These results
support the importance of experimental validation of
bioinformatically annotated functional predictions.
Fusion tags are one of several significant components
for successful expression and solubility levels of proteins
[54]. The most appropriate choice of fusion tags for
soluble expression of proteins is varied from target to
target. Therefore, a combination of fusion tags may
result in the highest recovery of soluble proteins. The
presence of recombinant signal peptide is also critical
for soluble expression and the maintenance of protein
activity [55]. Not only endogenous but also recombinant
signal sequences may be used by the translocation
machinery. It has been reported that codon optimized
signal peptides of eukaryotic origin were efficiently
translocated as recombinant protein into periplasm of
E. coli [56]. In the current study, we used a generic
E. coli signal peptide fused at the N-terminus to the
maltose binding protein since the native signal peptides
encoded by target proteins may not support proper
translocation of the target proteins. The native signal
peptides of target proteins can be used when using a C-
terminal fusion-tag system. Using the pSP-MBP vector,
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Figure 6 Protease activity screen using a fluorescence substrate, BZAR. A. The BZAR (Rhodamine 110, bis-(N-CBZ-L-arginine amide),
dihydrochloride) is a general substrate of serine proteases. Upon protease cleavage, the nonfluorescent bisamide derivative of rhodamine 110 is
first converted to the fluorescent monoamide and then to rhodamine 110, with a further increase in fluorescence. B. Time course measurements
of protease cleavage of BZAR. The protease cleavage reactions were montiored by time fluorescence measurements (lex: 485 nm, lem: 535 nm)
using a GENeo Pro (Tecan). The increase of fluorescence represents protease cleavage reactions. Δ: y3353, putative kinase, ○: trypsin, ◊: y1992:
putative carboxypeptidase, and □: SP1780, oligoendopeptidase.
Table 2 Summary of protease activity identification
Total purified
proteases
Activity
confirmed
Hypothetical
proteins
Activity
confirmed
Total 161 74 (46.0%) 44 19 (43.2%)
The protease activity was detected by either fluorescence assay using BZAR or
gelatin zymography.
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played protease activity. By contrast, 71.1% of the targets
were purified and only 11.3% displayed protease activity
when using pMBP. These results suggest that proper
translocation of some proteins into the E. coli periplasm,
where formation and isomerization of disulfide bonds
occurs, is significant for maintenance of protein activity
and stability [55,57]. The reduced purification success
observed when using pSP-MBP was due to low protein
solubility perhaps related to inefficient translocation to
the periplasmic space. It is possible that, the solubility of
SP-MBP tagged recombinant proteins could be
improved by expressing proteins in an E. coli strain
engineered to overexpress the periplasimc machinery
[52]. Alternatively, disulfide bond formation of target
proteins may be promoted in the cytoplasm using thior-
edoxin reductase deficient E. coli strains such as
BL21trx(DE3) [57-61].
Membrane proteins are very challenging targets. We
purified approximately 70% of the predicted membrane
proteins using the combination of 5 different fusion
tags. The majority of the purified membrane proteins
contain six or fewer transmembrane segments. The cor-
relation between the number of transmembrane seg-
ments in target proteins and purification success was
previously reported [62]. Only one membrane protein
was successfully purified using the His-tag, whereas the
large fusion tags, MBP, SP-MBP and DsbA enhanced
solubility of expressed membrane proteins resulting in
45.5%, 22.7% and 22.7% of the targets being successfully
purified, respectively. The combination of these large
fusion tags increases purification success rate of mem-
brane proteins. An alternative high throughput method
for membrane proteins encoding more than six trans-
membrane segments is the cell free expression strategy
using liposomes or detergent [63,64].
Conclusions
We modified a previously defined high throughput pro-
tein production and successfully adapted it for cloning,
expression and purification of a set of 187 proteases
using multiple Gateway compatible expression vectors.
The 96-well, 1 mL cell culture platform yields enough
protein for the combinatorial functional analyses using
high throughput fluorescence assays and zymography to
identify protease activity of the purified proteins. This
high throughput pipeline was successfully used for
experimental confirmation of gene annotation and
bioinformatics functional predictions, and can be easily
adapted for both initial screening of protein expression
and solubility for scale-up production for functional
and/or structural studies.
Methods
Construction of Gateway Compatible pET-destination
vectors
Construction of the pET-Dest-TIGR02 (abbreviation is
T02 or pHis) vector was previously described in Kwon
et al [29]. In addition to the T02, pET-Dest-TIGR221
(T221 or pMBP), pET-Dest-TIGR213 (T213 or pSP-
MBP) and pET-Dest-TIGR03 (T03 or pDsbA) were
constructed. The signal sequence deleted version of
the malE gene of pMAL-c2x (New England Biolabs,
Ipswich, MA) was used to construct T221. The malE
gene was amplified using three oligonucleotides in a
50 μL reaction with PCR High Fidelity Supermix (Invi-
trogen): 1) 20 pmoles PX006 for 5’ end of malE,2 )1
pmole PX007.2 for 3’ end of malE,a n d3 )2 0p m o l e s
PX0041 for addition of DNA sequence encoding the
TEV protease cleavage site at the carboxyl-terminus of
maltose binding protein (Table 3). The resulting pro-
ducts were purified using GFX DNA and Gel Band
Purification Kit (GE Healthcare, Piscataway, NJ) and
digested with PmlI. T02 vector was digested with PmlI
followed by treatment with CIP. The malE-TEV frag-
ment was ligated into the T02 vector using the Rapid
Ligase (Roche, Basel, Switzerland). DB3.1 [F
- gyrA462
endA1 Δsr1-recA) mcrB mrr hsdS20(rB
-,m B
-) supE44
ara14 galK2 lacY1 proA2 rpsL20(Sm
r) xyl5 Δleu mtl1]
cells (Invitrogen, Carlsbad, CA) were chemically trans-
formed and transformants were plated on LB agar con-
taining 100 μg/mL ampicillin and 34 μg/mL
chloramphenicol. Proper orientation of the cassette
was screened by PCR and the vector was validated by
DNA sequencing. Two expression vectors, pET-Dest-
TIGR213 (T213 or pSP-MBP) and pET-Dest-TIGR03
(T03 or pDsbA), containing signal peptide were con-
structed. With signal peptide The full malE gene of
pMAL-p2x (New England Biolabs) was amplified using
20 pmoles PX020, 1 pmole PX021, and 20 pmoles
PX029 in a 50 μL reaction with PCR High Fidelity
Supermix (Invitrogen) to construct T213. The full
dsbA gene of pET39b+ (EMD Biosciences) was ampli-
fied using 20 pmoles PX023, 1 pmole PX024, and 20
pmoles PX029 to construct T03. The sequences of oli-
gonucleotides are shown in Table 3. The resulting pro-
ducts were purified as described above and digested
with NcoI and KpnI. The pET45b+ (EMD Biosciences,
San Diego, CA) was digested with NcoI and KpnI fol-
lowed by treatment with CIP. The full malE-His-tag-
TEV and dsbA-His-tag-TEV fragments were ligated to
the pET45b+ backbone to create the pSP-MBP-His-tag
intermediate vector and pDsbA-His-tag, respectively.
The addition of the Gateway cassette rfc.1 to these
intermediate vectors parallels the T02.
Kwon et al. BMC Biochemistry 2011, 12:17
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Targets of putative proteases in Bacillus anthracis Ames,
Streptococcuss pneumoniae TIGR4 and Yersinia pestis Kim
were selected based on annotation of ORFs in J. Craig
Venter Institute Comprehensive Microbial Resource
(CMR) http://cmr.jcvi.org/tigr-scripts/CMR/CmrHome-
Page.cgi, PROSITE search http://au.expasy.org/tools/scan-
prosite/), TIGRFAM/PFAM search http://blast.jcvi.org/
web-hmm/. Presence of signal peptide was done using Sig-
nalP http://www.cbs.dtu.dk/services/SignalP/. Cellular
localization of the target proteins were predicted using
PSORT-B http://www.psort.org/psortb/[65].
Cloning, expression and purification
Entry clones used to construct expression clones were
obtained from the PFGRC http://pfgrc.jcvi.org/. The
pathogen entry clone sets are available from the Biode-
fense Emerging Infections Research Resources Reposi-
tory http://www.beiresources.org/: Bacillus anthracis
Ames (NR-19272), Streptococcus pneumoniae TIGR4
(NR-19278), and Yersinia pestis KIM (NR-19280).
Expression clones were generated by following the pro-
cedures as described in Kwon et al. [29]. The cloned
inserts were verified by DNA sequencing. The destina-
tion clones were transformed into BL21(DE3)pLysS
competent cells which were prepared using the Z-com-
petent E. coli transformation kit (Zymo Research,
Orange, CA), and frozen cultures were prepared as
described in Kwon et al. [29].
Recombinant proteins were overexpressed in BL21
(DE3)pLysS using five expression vectors, T02 (pHis),
T221 (pMBP), T213 (pSP-MBP), T213(pDsbA) and
pEXP7 (pGST). The cells were grown in 96-well 2 mL
blocks (Whatman Inc., Piscataway, NJ) containing 1 mL
2xYT medium, 100 μg/mL ampicillin and 34 μg/mL
chloramphenicol. The E. coli cells were incubated at
37°C in a Multitron incubator shaker (INFORS HT,
Bottmingen, Switzerland). When cells achieved an
OD600 nm between 0.7 and 0.9, 1 mM final concentra-
tion of isopropyl b-D-1-thiogalactopyranoside (IPTG)
was added to the cultures and incubated for an addi-
tional 18 to 20 hours at 25°C. Cells were harvested by
centrifugation at 2000 × g for 20 minutes, and the cell
pellets were stored at -20°C.
The recombinant proteins containing the His-tag were
purified using Ni-NTA agarose resin. Cell pellets were
resuspended in 0.4 mL low salt lysis buffer [50 mM
Tris-HCl, 100 mM NaCl, 5 mM imidazole, 1 mM DTT,
p H8 . 0a t4 ° C ]w i t h1 . 2μL Lysonase Bioprocess (EMD
Biosciences). Each cell suspension was incubated on ice
for 20 minutes and 65 μL PopCulture (EMD Bioscience)
was added to lyse the cells completely. The lysates were
incubated on a microtiter plate shaker at 4°C for 30
minutes and the NaCl concentration was adjusted to
300 mM. Soluble fractions were separated by centrifuga-
tion at 2400 × g at 4°C for 1 hour in a bench top centri-
fuge (Eppendorf, 5810R). The supernatants were applied
to 96-well filter blocks containing 100 μL Ni-NTA agar-
ose resin (50% v/v slurry) in a Whatman 2 mL Unifilter
block with GF/C filter (Whatman Inc.). The block was
sealed with a capmat and a parafilm-covered v-bottom
96-well plate and rotated on the tube rotator for 1 hour
in the cold room to bind the protein to resin. The resins
were collected by quick centrifugation and buffer was
removed using an automated liquid handler, Biomek FX.
The parafilm-covered 96-well plate was removed from
the filter block and the filter block was placed on a new
deep-well block. The resin was washed with 500 μL
wash buffer [50 mM Tris-HCl, 10 mM imidazole, 300
mM NaCl, 1 mM DTT, 0.1% Triton X-100, pH 8.0 at 4°
C] 5 times. Recombinant proteins were eluted in 150 μL
[50 mM Tris-HCl, 300 mM NaCl, 200 mM imidazole, 1
mM DTT, pH 8.0 at 4°C] twice, and imidazole was
removed by exchange into storage buffer [50 mM Tris-
HCl, 300 mM NaCl, 5% glycerol, 1 mM DTT, pH 7.5 at
4°C] using an Ultracel-10 96-well filtration devices
(Millipore, Billerica, MA). Purity levels of the resulting
proteins were confirmed on Nu-PAGE gels (Invitrogen,
Carlsbad, CA). Recombinant proteins visualized by Nu-
PAGE were subjected to in-gel digestion with trypsin,
and their identities were determined by MALDI-TOF/
TOF analysis as previously described [66]. The purified
protein concentrations were determined by absorbance
at 280 nm using a GENios Pro plate reader (Tecan).
Table 3 Oligonucleotide sequences used for construction of expression vectors
Name Oligonucleotide sequence
PX006 GGGGCACGTGGGTATGAAAATCGAAGAAGGTAAACTG
PX007.2 CTGGAAGTACAGGTTCTCACCGCTCGAATTAGTCTGCGCGTC
PX0041 GGGGCACGTGACCACCCTGGAAGTACAGGTCTC
PX0020 GGGGCCATGGCAATGAAAATAAAAACAGGTGCACGCA
PX0021 GTGATGGTGGTGGTGATGACCCGAACCGCTCGAGCTCGAATTAGTCTGCGC
PX0023 GGGGCCATGGCTATGAAAAAGATTTGGCTGGCGCTGG
PX0024 GTGATGGTGGTGGTGATGACCCGAACCGCTAGTTGATCCTTTTTTCTCGCTTAAGTATTTCAC
PX0029 GGGGGGTACCACCACCCTGGAAGTACAGGTTCTCACCGGCCGAGTGATGGTGGTGGTGAT
Kwon et al. BMC Biochemistry 2011, 12:17
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was calculated from amino acid sequence of the fusion
tag and the target protein [67]. Purified proteins were
stored at -80°C. The GST-tagged proteins were purified
by following the same procedure for His-tagged protein
purification using glutathione agarose resin and GST
elution buffer [50 mM Tris-HCl, pH 8.0 at 4°C, 1%
reduced glutathione].
Zymography
Zymography was performed with 10% Tris-Glycine gels
containing 0.1% gelatin (Invitrogen) as a substrate. Initi-
ally, the protease samples in the range of 10 ng to 5 μg
were denatured with SDS sample buffer and subjected
to electrophoresis at room temperature. After electro-
phoresis, gels were removed and incubated in Zymo-
gram Renaturing Buffer (Invitrogen) for 30 minutes at
room temperature with gentle agitation to renature the
separated proteases by replacing SDS. The gels were
then equilibrated in Zymogram Developing Buffer con-
taining divalent metal cation suitable for enzymatic
activity (Invitrogen) for 30 minutes at room temperature
with gentle agitation. After decanting the buffer, fresh
1× Zymogram Developing Buffer was added to the gels.
The gels were then at 37°C overnight for maximum sen-
sitivity. The protease activity was visualized by staining
with Coomassie Brilliant Blue R250 and destaining thor-
oughly in destaining solution [5% methanol, 7.5% acetic
acid]. Areas of digestion appearing clear against a dark
blue background represent enzymatic activity.
Fluorescence measurements
Fluorescence substrates, BZAR (rhodamine 110, bis-
(CBZ-L-arginine amide), dihydrochloride) and DQ gela-
tin were used to detect protease activity of purified pro-
teins. The reaction with BZAR was initiated by adding 5
μL purified protein stock into 45 μL3 0n Ms u b s t r a t e
prepared in reaction buffer [10 mM Tris pH 7.5 at 25°C,
100 μg/mL BSA] in a half-size 96-well plate. Time
course fluorescence measurements of the reactions were
made at lex = 485 nm and lem = 535 nm using GENios
Pro (Tecan). In each well of a 96-well plate, 45 μL 12.5
μg/mL DQ gelatin was prepared in DQ-gelatin reaction
buffer [50 mM Tris-HCl, 150 mM NaCl, 5 mM CaCl2,
pH 7.6] and proteolysis reaction was performed by add-
ing 5 μL purified proteins. The reactions were incubated
at 25°C and time course fluorescence measurements
were performed at the same setting as BZAR assays.
Additional material
Additional file 1: Table S1 - Data table of protease preparation in
five expression vectors and protease activity assay. The selected
proteases of Streptococcus pneumoniae, Bacillus anthracis and Yersinia
pestis were cloned into five expression vectors, pHis (T02), pMBP (T221),
pSP-MBP (T213), pDsbA (T03) and pGST (pEXP7). Data from cloning to
protease assay are presented for expression vector. “LR” column
represents LR cloning of target ORFs from entry clone. Scores “1” and “0”
in “LR” column represent “success” and “fail”, respectively. Transformation
column represents the number of colonies after transformation into BL21
(DE3)pLysS. The scores, “0”, “1”, “2”, and “3” in the columns of ‘Expression’
and ‘Solubility’ represent none, low, medium and high expression and
solubility, respectively. “[Purified] μg/mL” is the concentration of purified
recombinant protein and “Purified (PAGE)” for pGST (pEXP7) represents
success ("1”) or fail ("0”) in purification. “BZAR (S/N)” is the ratio of
fluorescence in the presence to the absence of protease after 1 hour
incubation. “BZAR (slope)” is the rate of fluorescence change in the
presence of a given protease. Combining S/N and slope, protease activity
to BZAR was determined and the result is shown in column of “BZAR”.
The column of “Gelatin” is the result of gelatin zymography, and the
numbers represent relative activity-1: weak. 2: medium and 3: strong.
“DQ (slope)” is the rate of fluorescence change in the presence of a
given protease. “Family” column described peptidase family grouped,
and the first letter represents catalytic type: A, aspartic; C, cystein,; M,
metallic; S, serine; and U, unknown.
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